PCVX
NASDAQ
$58.04
Vaxcyte Inc (PCVX)
Vaxcyte, Inc., a pre-clinical biotech vaccine company, develops novel vaccines to prevent or treat infectious diseases globally. The company is headquartered in Foster City, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $109 (+87.80%)
Market Cap
$8.19B
EPS 5Y CAGR
+33.90%
FCF 5Y CAGR
+66.90%
Free Cash Flow Yield
-9.53%
Price Chart
Valuation
Market Cap$8.19B
P/B2.71
Profitability
Gross Profit (TTM)-$75M
EBITDA-$1.07B
EPS-$7.02
Financial Health
Free Cash Flow Yield-9.53%
Growth & Risk
EPS 5Y CAGR+33.90%
FCF 5Y CAGR+66.90%
Beta (5Y)0.73
Sharpe Ratio1.00